2Watanabe T,Egawa M.Effects of an antistroke agent MCI-186 on cerebral arachidonate cade.J Pharmacol Exp Ther,1994,271(3):1624-1629.Tioxidant actions[J].J Phatmacol Exp Ther,1994,268:597-604.
3Amemiya S,Kamiya K Nito C,et al.Anti-apoptotie and neu-rnprntective effects of edaravone following transient focal ischemia in rats.Eur J,2005,6(1):125-130.
416 Tosaka M,Hashiba Y,Saito N,et al.Contractile respnnse to reactive oxygen species in the caine bassilar artery in vitro;se-lective inhibiting effect of MCI-186,a new hydroxyl radical Scavenger.Acta Neurnehir (Wien),2002,144 (12):1305,1310:discussion 1310.
3Nakamoto N, Tada S, Kameyama K, et al. A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory eytokine production in rat acute liver injury. Free radical Research, 2002 , 37 ( 8 ) : 849-859.
4Mikawa K, Akamatsu H, Nishina K, et al. Effects of edaravone on human neutrophil function. Acta Anaesthesiol Scand,2005, 49(3) : 385-389
6Mizuno A, Umemura K, Nakashima M, et al. Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle artery occlusion. Gen pharmaco, 1998, 30(4): 575-578.
7Watanabe T, Egawa M. Effects of an antistroke agent MCI-186 on cerebral arachidonatc cascades. J Pharmacol Exp Ther,1994, 271(3): 1624-1629.
8Shichinohe H, Kuroda S, Yasuda H, et al. neuroprotective effects of the free radical (MCI-186) in mice permanent focal brain ischemia. Brain Res, 2004, 1029(2): 200-206.
9Amemiya S, Kamiya K Nito C, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J, 2005, 6(1) : 125-130.
10Yasuoka N, Nakajima W, Ishida A, et al. Neuroprotection of edaravone of hypoxic-ischemic brain injury in neonatal rats.Brain Res Dev Brain Res, 2004, 7(19) : 129-139.
